The eVTOL tape still looks selective, not broad-based. In the latest completed U.S. session, JOBY closed at $8.63, down 2.27% on 47,668,114 shares, ACHR closed at $4.68, down 3.90% on 34,686,925 shares, and EH closed at $6.33, up 3.26% on 995,442 shares, while the U.S. 10Y Treasury yield held at 4.37% and Fed funds stayed at 3.63%. The way I see it, today’s setup was less about who finished green for one session and more about who still controls institutional mindshare across the eVTOL complex.
For today’s detailed market data, see Joby Daily, Archer Daily, and EHang Daily.
Does EHang’s green close signal a real sector-ranking shift, or do Joby and Archer still hold the lead?
Joby and Archer still hold the institutional lead. EHang’s green day looks more like an oversold bounce than a confirmed ranking change.
Start with the ownership signal, because that is still the clearest map of sector hierarchy. ARKX shows ACHR at 3.00% and JOBY at 2.58% as of Jun. 28, while EH is not visible in the top 25 holdings. When a sector ETF is willing to carry the two U.S. names at visible weights and EHang still does not show up on that list, that says capital allocators remain more comfortable expressing the eVTOL theme through Joby and Archer. That is not a valuation opinion by itself, but it is a ranking signal.
Now look at the tape. EH closed at $6.33, up 3.26%, while JOBY fell 2.27% to $8.63 and ACHR fell 3.90% to $4.68. If you stopped there, you could argue that the market is quietly starting to rotate toward EHang. But the volume profile does not back that up. EH traded only 995,442 shares. JOBY traded 47,668,114 shares and ACHR traded 34,686,925 shares. That is not a close call. EHang’s move happened on a fraction of the capital and attention flowing through the U.S. names.
The technical context pushes the same way. EH is still below SMA5 at 6.38 and well below SMA20 at 7.51, with RSI14 at 27.38. Those are oversold numbers, not leadership numbers. A real rerating usually starts with price strength that pulls the stock back through near-term trend levels and brings in broader participation. EH got the first part of that process for one day, but not the second. The stock rose, yet it still sits under both moving averages and still lacks the trading intensity that would suggest institutions are treating it as the sector’s new primary vehicle.
Joby and Archer are not healthy either. JOBY is below SMA5 at 9.03 and SMA20 at 9.79, and ACHR is below SMA5 at 4.93 and SMA20 at 5.53. Both are weak. Still, weakness inside the leaders is not the same thing as leadership changing hands. Right now, it means the sector is under pressure and the names with the deepest sponsorship are also getting sold.
So the clean read is this: EHang won the day, but it did not win the ranking. My read is constructive on the possibility of a tactical EH bounce, but still cautious on any claim that the sector order has changed. To change that conclusion, EH would need more than a single green close. It would need repeated outperformance, volume that starts to close the gap with JOBY and ACHR, and ideally a fresh official milestone that turns Stage 5 from a stale advantage into a live catalyst. Until then, the sector order still looks like JOBY and ACHR in the institutional front row, with EH as the regulatory outlier that the market is not yet willing to own at scale.
External references reviewed for this question included the ARKX holdings page, Joby Aviation news releases, and Archer Aviation investor releases.
Was Joby’s 47.7 million-share session support buying, or was it distribution?
The balance of evidence leans toward distribution-heavy churn, not clean support buying.
Let’s break this down. JOBY traded 47,668,114 shares and still closed down 2.27% at $8.63. That is the first clue. If the session were clearly dominated by support buying, you would want to see the stock absorb that volume and either finish flat or push higher. Instead, the price ended lower and stayed well below SMA5 at 9.03 and SMA20 at 9.79. The gap to SMA20 is still large at $1.16, which tells you the stock is not just wobbling around trend. It is still trading materially beneath it.
The second clue is the catalyst backdrop. Joby’s daily report says no new official in-window item was confirmed, and the article-summary file says there was no Joby-related article. So the market produced almost 47.7 million shares of turnover without a fresh official company trigger. When volume explodes in the absence of new information and price still fades, that usually looks less like conviction accumulation and more like repositioning, profit-taking, or trend-following exits colliding with bargain hunting.
RSI14 at 37.92 matters too. It is weak, but not fully washed out. In other words, Joby is soft enough to attract dip buyers, yet not so stretched that the tape had to snap back aggressively. That creates the kind of market where both sides can show up: longer-horizon buyers may absorb stock because the name remains one of the core eVTOL exposures, while shorter-horizon holders and momentum traders use the liquidity to lighten up.
Relative volume also helps frame it. ACHR traded 34,686,925 shares and fell 3.90%. EH traded only 995,442 shares and rose 3.26%. Joby’s 47.7 million-share print was the heaviest among the three, and it came in a session where the U.S. leaders were both red. That looks more like a pressure session inside the sponsored names than a quiet stabilization day.
Could there still have been institutional absorption? Yes, some of it almost certainly existed, because a stock does not trade that much volume on one side only. ARKX still carries JOBY at 2.58%, and the daily report detected no institutional changes. But that last point is important: no institutional changes were detected. Without a confirmed increase in fund ownership or a fresh company catalyst, there is no evidence strong enough to call the move deliberate support buying.
So my answer is directional: this was not a bullish defense day. I think the session was closer to distribution than accumulation, even if some larger buyers were present underneath. The better test comes next. If that kind of volume starts appearing alongside closes above SMA5 or with a new official milestone, then you can argue institutions used the weakness to build. On the current evidence, the tape still says sellers had the stronger hand, which keeps my lean cautious.
External references reviewed for this question included the ARKX holdings page, Joby Aviation news releases, and CNBC market data for JOBY.
When does EHang’s regulatory lead start showing up in the stock again after an 18-day stall?
It probably does not get paid for again until the next official milestone turns that lead from static to active.
EHang’s tracker still shows Stage 5, last confirmed on 2026-06-12. On paper, that should be a major differentiator. In a sector where certification and regulatory progress are the gating variables, being further along should matter. The problem is that the market has already absorbed that fact. After 18 days without a new official update, the lead is no longer fresh information. It is background information.
The stock’s current setup reflects exactly that. EH closed at $6.33, which is still below SMA5 at 6.38 and well below SMA20 at 7.51. RSI14 is 27.38, which is deeply oversold. Volume was only 995,442 shares. Those numbers tell a pretty blunt story: the market is willing to let EHang bounce tactically, but it is not yet willing to rerate the company as if the Stage 5 edge is accelerating into a new phase.
Why not? Because a dormant lead does not force buyers to act. Investors want to know what comes next. The EHang daily report frames the next meaningful step as broader regulatory durability and repeatable commercial scaling, with the main hurdles still around certification breadth, operational standardization, and sustained demand conversion. That is the missing bridge. Stage 5 says EHang has progress. It does not, by itself, answer how quickly that progress converts into visible commercial scale or renewed institutional attention.
The attention gap versus the U.S. peers is the other issue. Even on a day when EH outperformed on price, JOBY and ACHR still dominated turnover. Joby traded almost 48 times EH’s volume. Archer traded almost 35 times EH’s volume. When that much more money is moving through the U.S. names, the market is telling you where the debate still lives. EHang may have the more interesting regulatory talking point, but Joby and Archer still own more of the portfolio conversation.
So when does the market pay up again? Not on silence. Not on one oversold bounce. My view is neutral-to-constructive on the setup only if the next proof point lands. That proof point could be a new certification-related confirmation, a concrete operating expansion, or another milestone that makes commercialization look closer and more repeatable. Without that, the stock can keep producing short-covering or mean-reversion days while still trading below trend. Until then, the lead remains real, but the premium attached to it stays thin.
External references reviewed for this question included EHang investor relations, EHang company news, and ARKX holdings.
What to Watch Tomorrow
- First, watch whether EHang can post a second straight session of relative outperformance while volume rises above today’s 995,442 shares.
- Second, watch whether Joby can absorb heavy turnover and reclaim at least its SMA5 area near 9.03 instead of extending the current pressure leg.
- Third, watch whether Archer delivers any official catalyst strong enough to interrupt its current weakness below SMA5 at 4.93 and SMA20 at 5.53.
This is not financial advice. Do your own research.
Follow @futurewatchlog for daily eVTOL coverage.
Previous insight: https://futurewatchlog.com/2026/06/29/evtol-daily-insight-2026-06-29/